Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
If you already started treatment before these changes, you can continue with your prescription
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and manage chronic weight in adults with obesity
This gap is large enough to keep patients using injectable options in most cases
Switching away from AOM semaglutide and AOM tirzepatide Prior to May 2025, patients with an active supply of AOM semaglutide or AOM tirzepatide during a given month rarely switched to a different drug
US$ 24.87
US$ 29.27
US$ 23.22
US$ 21.63
US$ 21.31
US$ 21.09
US$ 27.15
US$ 27.45
